SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
Alnylam Pharmaceuticals Receives Notice of Allowance From United States Patent and Trademark Office (USPTO) for New Patents From the Tuschl II Patent Estate Broadly Covering RNAi Therapeutics